Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
Kimberley Stannard, P.M. Collins, Koichi Ito, et al.
Cancer Letters (2010) Vol. 299, Iss. 2, pp. 95-110
Closed Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
Tomás Dalotto‐Moreno, Diego O. Croci, Juan P. Cerliani, et al.
Cancer Research (2012) Vol. 73, Iss. 3, pp. 1107-1117
Open Access | Times Cited: 240
Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
Hannah Barrow, Xiuli Guo, Hans H. Wandall, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 22, pp. 7035-7046
Open Access | Times Cited: 159
High expression of Galectin‐1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer
Dong Tang, Zhongxu Yuan, Xiaofeng Xue, et al.
International Journal of Cancer (2011) Vol. 130, Iss. 10, pp. 2337-2348
Open Access | Times Cited: 151
Galectin-1 research in T cell immunity: Past, present and future
Filiberto Cedeno‐Laurent, Charles J. Dimitroff
Clinical Immunology (2011) Vol. 142, Iss. 2, pp. 107-116
Open Access | Times Cited: 144
Bio-production of lactobionic acid: Current status, applications and future prospects
Saúl Alonso, Manuel Rendueles, Mario Dı́az
Biotechnology Advances (2013) Vol. 31, Iss. 8, pp. 1275-1291
Closed Access | Times Cited: 130
Lactobionic acid: A high value-added lactose derivative for food and pharmaceutical applications
Luis‐Felipe Gutiérrez, Safia Hamoudi, Khaled Belkacemi
International Dairy Journal (2012) Vol. 26, Iss. 2, pp. 103-111
Closed Access | Times Cited: 121
Galectin-9 in tumor biology: A jack of multiple trades
Roy Heusschen, Arjan W. Griffioen, Victor L. Thijssen
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2013) Vol. 1836, Iss. 1, pp. 177-185
Closed Access | Times Cited: 119
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Koichi Ito, Kimberley Stannard, Elwyn Gabutero, et al.
Cancer and Metastasis Reviews (2012) Vol. 31, Iss. 3-4, pp. 763-778
Open Access | Times Cited: 116
Galectin-3 inhibitors: a patent review (2008–present)
Helen Blanchard, Xing Yu, P.M. Collins, et al.
Expert Opinion on Therapeutic Patents (2014) Vol. 24, Iss. 10, pp. 1053-1065
Closed Access | Times Cited: 96
Galectin-1: A Traditionally Immunosuppressive Protein Displays Context-Dependent Capacities
Xizhi Yu, Junjie Qian, Limin Ding, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6501-6501
Open Access | Times Cited: 25
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
Koichi Ito, Stacy A. Scott, Samuel J. Cutler, et al.
Angiogenesis (2011) Vol. 14, Iss. 3, pp. 293-307
Open Access | Times Cited: 98
Involvement of galectin-1 in reproduction: past, present and future
Gabriela Barrientos, Nancy Freitag, Irene Tirado‐González, et al.
Human Reproduction Update (2013) Vol. 20, Iss. 2, pp. 175-193
Open Access | Times Cited: 83
Mechanism of immune evasion in breast cancer
Mozhi Wang, Changwang Zhang, Yongxi Song, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 1561-1573
Open Access | Times Cited: 81
Glioma‐derived galectin‐1 regulates innate and adaptive antitumor immunity
Tina Verschuere, Jaan Toelen, Wim Maes, et al.
International Journal of Cancer (2013) Vol. 134, Iss. 4, pp. 873-884
Open Access | Times Cited: 80
Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors
Tung-Ju Hsieh, Hsien-Ya Lin, Zhijay Tu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 79
Galectin-1 inhibitors and their potential therapeutic applications: a patent review
Helen Blanchard, Khuchtumur Bum‐Erdene, M.H. Bohari, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 5, pp. 537-554
Closed Access | Times Cited: 77
Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways
Gabriel A. Rabinovich, José R. Conejo-García
Journal of Molecular Biology (2016) Vol. 428, Iss. 16, pp. 3266-3281
Open Access | Times Cited: 76
A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion
Anne-Elisabeth Petit, Nathalie Demotte, Benoît Scheid, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 67
Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
Yanyu Huang, Hsiao-Chi Wang, Junwei Zhao, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1398-1398
Open Access | Times Cited: 41
Neuroblastoma triggers an immunoevasive program involving galectin‐1‐dependent modulation of T cell and dendritic cell compartments
Rocío Soldati, Elisa Berger, Ana Claudia Zenclussen, et al.
International Journal of Cancer (2011) Vol. 131, Iss. 5, pp. 1131-1141
Open Access | Times Cited: 75
Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence
Koichi Ito, Stephen J. Ralph
Clinical & Experimental Metastasis (2012) Vol. 29, Iss. 6, pp. 561-572
Closed Access | Times Cited: 70
Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity
Filiberto Cedeno‐Laurent, Matthew Opperman, Steven R. Barthel, et al.
Journal of Investigative Dermatology (2011) Vol. 132, Iss. 2, pp. 410-420
Open Access | Times Cited: 62
Galectins and their ligands: negative regulators of anti-tumor immunity
Filiberto Cedeno‐Laurent, Charles J. Dimitroff
Glycoconjugate Journal (2012) Vol. 29, Iss. 8-9, pp. 619-625
Open Access | Times Cited: 59
Self-Assembled Glycopeptide Nanofibers as Modulators of Galectin-1 Bioactivity
Antonietta Restuccia, Ye Tian, Joel H. Collier, et al.
Cellular and Molecular Bioengineering (2015) Vol. 8, Iss. 3, pp. 471-487
Open Access | Times Cited: 57
Galectin-1 Regulates Tissue Exit of Specific Dendritic Cell Populations
Sandra Thiemann, Jeanette H. Man, Margaret H. Chang, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 37, pp. 22662-22677
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top